CoChat
Sign Up
Cited by 1,841Frailty in Older AdultsNutrition and Health in AgingPharmaceutical Practices and Patient Outcomes

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

Open access
Hurria, Arti, Togawa, Kayo, Mohile, Supriya G., Owusu, Cynthia, Klepin, Heidi D., Gross, Cary P., Lichtman, Stuart M., Gajra, Ajeet, Bhatia, Smita, Katheria, Vani, Klapper, Shira, Hansen, Kurt, Ramani, Rupal, Lachs, Mark, Wong, F. Lennie, Tew, William P.·2011·Journal of Clinical Oncology
DOI 10.1200/jco.2011.34.7625PMC PMC3624700
Open this paper in CoChat — free accountOpen PDF

Abstract

Purpose: Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals of this study are to identify risk factors for chemotherapy toxicity in older adults and develop a risk stratification schema for chemotherapy toxicity. Patients and Methods: Patients age ≥ 65 years with cancer from seven institutions completed a prechemotherapy assessment that captured sociodemographics, tumor/treatment variables, laboratory test results, and geriatric assessment variables (function, comorbidity, cognition, psychological state, social activity/support, and nutritional status). Patients were followed through the chemotherapy course to capture grade 3 (severe), grade 4 (life-threatening or disabling), and grade 5 (death) as defined by the National Cancer Institute Common Terminology Criteria for Adverse Events. Results: In total, 500 patients with a mean age of 73 years (range, 65 to 91 years) with stage I to IV lung (29%), GI (27%), gynecologic (17%), breast (11%), genitourinary (10%), or other (6%) cancer joined this prospective study. Grade 3 to 5 toxicity occurred in 53% of the patients (39% grade 3, 12% grade 4, 2% grade 5). A predictive model for grade 3 to 5 toxicity was developed that consisted of geriatric assessment variables, laboratory test values, and patient, tumor, and treatment characteristics. A scoring system in which the median risk score was 7 (range, 0 to 19) and risk stratification schema (risk score: percent incidence of grade 3 to 5 toxicity) identified older adults at low (0 to 5 points; 30%), intermediate (6 to 9 points; 52%), or high risk (10 to 19 points; 83%) of chemotherapy toxicity (P < .001). Conclusion: A risk stratification schema can establish the risk of chemotherapy toxicity in older adults. Geriatric assessment variables independently predicted the risk of toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2011.34.7625

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

1 of the 43 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

See all 1,841

Related

See all

Metadata

Authors
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., Klapper, S., Hansen, K., Ramani, R., Lachs, M., Wong, F. L., & Tew, W. P.
Affiliations
  • City Of Hope National Medical Center (US)
  • Arti Hurria, Kayo Togawa, Smita Bhatia, Rupal Ramani, and F. Lennie Wong, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte; Kurt Hansen, University of California Davis School of Medicine, Sacramento, CA; Supriya G. Mohile, University of Rochester Medical Center, Rochester; Stuart M. Lichtman, Shira Klapper, and William P. Tew, Memorial Sloan-Kettering Cancer Center; Mark Lachs, Weill Cornell Medical College, New York; Ajeet Gajra, State University of New York Upstate...
ORCID
Venue
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Published
2011-09-01
Volume
29
Issue
25
Pages
3457-3465
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
DOI
10.1200/jco.2011.34.7625
PMC
PMC3624700
OpenAlex
W2153294383
Cited by
1,841
References
43
Citations by year
2026: 98 · 2025: 98 · 2024: 117 · 2023: 119 · 2022: 153 · 2021: 149 · 2020: 148 · 2019: 147 · 2018: 143 · 2017: 129 · 2016: 134 · 2015: 114 · 2014: 112 · 2013: 87 · 2012: 73
FWCI
43.61
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Amgen
  • GlaxoSmithKline
  • American Society of Clinical Oncology
  • Celgene
  • Genentech
  • National Institute on Aging (K24AG022399, 1K08 AG 24842, K08AG024842, K23AG038361, K23AG026749)
  • National Cancer Institute (U10CA098543)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
chemotherapy toxicity, older adults, geriatric assessment, risk stratification, risk prediction model, comorbidities, functional status, nutritional status, cognitive status, laboratory parameters, geriatric oncology
MeSH terms
Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Neoplasms, Predictive Value of Tests, Prospective Studies, Comorbidity, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review